These effects, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the strategy of focusing on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders. Morphine as well as https://whatischronicpain43097.daneblogger.com/31666150/top-guidelines-of-conolidine